Antiplatelet (aspirin) therapy as a new option in the treatment of vasculogenic erectile dysfunction: a prospective randomized double-blind placebo-controlled study.
about
Antiplatelet (aspirin) therapy as a new option in the treatment of vasculogenic erectile dysfunction: a prospective randomized double-blind placebo-controlled study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Antiplatelet (aspirin) therapy ...... lind placebo-controlled study.
@en
Antiplatelet
@nl
type
label
Antiplatelet (aspirin) therapy ...... lind placebo-controlled study.
@en
Antiplatelet
@nl
prefLabel
Antiplatelet (aspirin) therapy ...... lind placebo-controlled study.
@en
Antiplatelet
@nl
P2860
P1476
Antiplatelet (aspirin) therapy ...... lind placebo-controlled study.
@en
P2093
Selami Albayrak
P2860
P304
P356
10.1007/S11255-018-1786-0
P577
2018-01-17T00:00:00Z